116 related articles for article (PubMed ID: 6105058)
1. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.
Duggan DE; Hooke KF; Hwang SS
Drug Metab Dispos; 1980; 8(4):241-6. PubMed ID: 6105058
[TBL] [Abstract][Full Text] [Related]
2. Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium.
Duggan DE
Drug Metab Rev; 1981; 12(2):325-37. PubMed ID: 7040018
[TBL] [Abstract][Full Text] [Related]
3. Dimethyl sulfoxide inhibits bioactivation of sulindac.
Swanson BN; Boppana VK; Vlasses PH; Rotmensch HH; Ferguson RK
J Lab Clin Med; 1983 Jul; 102(1):95-101. PubMed ID: 6854139
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of sulindac metabolism by dimethyl sulfoxide in the rat.
Swanson BN; Mojaverian P; Boppana VK
J Toxicol Environ Health; 1983; 12(2-3):213-22. PubMed ID: 6655731
[TBL] [Abstract][Full Text] [Related]
5. Sulfoxide reduction. In vitro reduction of sulindac by rat hepatic cytosolic enzymes.
Ratnayake JH; Hanna PE; Anders MW; Duggan DE
Drug Metab Dispos; 1981; 9(2):85-7. PubMed ID: 6113122
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin-dependent sulfoxide reduction by rat renal cytosol.
Anders MW; Ratnayake JH; Hanna PE; Fuchs JA
Drug Metab Dispos; 1981; 9(4):307-10. PubMed ID: 6114827
[TBL] [Abstract][Full Text] [Related]
7. Identification of the biologically active form of sulindac.
Duggan DE; Hooke KF; Risley EA; Shen TY; Arman CG
J Pharmacol Exp Ther; 1977 Apr; 201(1):8-13. PubMed ID: 850147
[TBL] [Abstract][Full Text] [Related]
8. Renal metabolism of sulindac: functional implications.
Miller MJ; Bednar MM; McGiff JC
J Pharmacol Exp Ther; 1984 Nov; 231(2):449-56. PubMed ID: 6436473
[TBL] [Abstract][Full Text] [Related]
9. Effect of dimethyl sulfoxide on sulindac disposition in rats.
Swanson BN; Mojaverian P; Boppana VK; Dudash MR
Drug Metab Dispos; 1981; 9(6):499-502. PubMed ID: 6120805
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of graded oral doses of sulindac in man.
Mattila J; Mäntylä R; Vuorela A; Lamminsivu U; Männistö P
Arzneimittelforschung; 1984; 34(2):226-9. PubMed ID: 6539116
[TBL] [Abstract][Full Text] [Related]
11. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. I. An application of pharmacokinetic model for reversible metabolism.
Lin JH; Yeh KC; Duggan DE
Drug Metab Dispos; 1985; 13(5):602-7. PubMed ID: 2865111
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation of sulindac in end-stage renal disease.
Gibson TP; Dobrinska MR; Lin JH; Entwistle LA; Davies RO
Clin Pharmacol Ther; 1987 Jul; 42(1):82-8. PubMed ID: 3595070
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of Sulindac.
Kwan KC; Duggan DE
Acta Rhumatol Belg; 1977; 1(3-4):168-78. PubMed ID: 756665
[No Abstract] [Full Text] [Related]
14. In vitro metabolism of sulindac and sulindac sulfide: enzymatic formation of sulfoxide and sulfone.
Kitamura S; Tatsumi K
Jpn J Pharmacol; 1982 Oct; 32(5):833-8. PubMed ID: 7176218
[TBL] [Abstract][Full Text] [Related]
15. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
16. Biliary secretion of sulindac and metabolites in man.
Dobrinska MR; Furst DE; Spiegel T; Vincek WC; Tompkins R; Duggan DE; Davies RO; Paulus HE
Biopharm Drug Dispos; 1983; 4(4):347-58. PubMed ID: 6661513
[TBL] [Abstract][Full Text] [Related]
17. Metabolism in vitro of sulindac. Sulfoxide-reducing enzyme systems in guinea pig liver.
Kitamura S; Tatsumi K; Yoshimura H
J Pharmacobiodyn; 1980 Jun; 3(6):290-8. PubMed ID: 6775073
[TBL] [Abstract][Full Text] [Related]
18. Disposition and metabolism of fenbufen in several laboratory animals.
Chiccarelli FS; Eisner HJ; Van Lear GE
Arzneimittelforschung; 1980; 30(4A):707-15. PubMed ID: 6776965
[TBL] [Abstract][Full Text] [Related]
19. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. II. Differential effects on the biliary excretion.
Lin JH; Yeh KC; Duggan DE
Drug Metab Dispos; 1985; 13(5):608-13. PubMed ID: 2865112
[TBL] [Abstract][Full Text] [Related]
20. Analysis of sulindac and metabolites in plasma and urine by high-performance liquid chromatography.
Stubbs RJ; Ng LL; Entwistle LA; Bayne WF
J Chromatogr; 1987 Jan; 413():171-80. PubMed ID: 3558666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]